ERBB2 and breast cancer: This demonstrated that HMGA2 promoter methylation was significantly lower in the TNBC and HER2+ breast cancer tissues compared to luminal breast cancer tissues (p = 9.43 × 10−4) and normal tissues (p = 4.78 × 10−11) (Figure 1A).